Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
Leukemia ( IF 12.8 ) Pub Date : 2017-09-19 , DOI: 10.1038/leu.2017.266
A Nazha , K Al-Issa , B K Hamilton , T Radivoyevitch , A T Gerds , S Mukherjee , V Adema , A Zarzour , N Abuhadra , B J Patel , C M Hirsch , A Advani , B Przychodzen , H E Carraway , J P Maciejewski , M A Sekeres

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

Leukemia advance online publication, September 19 2017. doi:10.1038/leu.2017.266

Authors: A Nazha, K Al-Issa, B K Hamilton, T Radivoyevitch, A T Gerds, S Mukherjee, V Adema, A Zarzour, N Abuhadra, B J Patel, C M Hirsch, A Advani, B Przychodzen, H E Carraway, J P Maciejewski & M A Sekeres

中文翻译：

在预后模型中增加分子数据可以改善治疗后的骨髓增生异常综合征患者的预测能力

白血病提前在线发布，2017年9月19日。doi：10.1038 / leu.2017.266

作者：A Nazha，K Al-Issa，BK Hamilton，T Radivoyevitch，AT Gerds，S Mukherjee，V Adema，A Zarzour，N Abuhadra，BJ Patel，CM Hirsch，A Advani，B Przychodzen，HE Carraway，JP Maciejewski和MA塞克斯

更新日期：2017-09-19

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11